
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $921K | $1.1M | $1.9M | $4.2M | $6M | |
Revenue Growth (YoY) | -41.11% | 17.7% | 77.03% | 118.4% | 43.9% | |
Cost of Revenues | $1.6M | $5K | -- | -- | -- | |
Gross Profit | -$685K | $1.1M | -- | -- | -- | |
Gross Profit Margin | -74.38% | 99.54% | -- | -- | -- | |
R&D Expenses | $4.3M | $3.6M | $4.4M | $5.7M | $5.7M | |
Selling, General & Admin | $42.2M | $44M | $50.9M | $50.1M | $48.8M | |
Other Inc / (Exp) | -$3.6M | $11.4M | $38.7M | $42.6M | $37.4M | |
Operating Expenses | $50.1M | $49M | $56.8M | $56.7M | $55.1M | |
Operating Income | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$54.3M | -$36.5M | -$15.1M | -$7.5M | -$9.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $124K | $983K | $1.3M | $1.6M | $1.9M | |
Net Income to Company | -$54.4M | -$37.5M | -$16.3M | -$9.1M | -$11.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$54.4M | -$37.5M | -$16.3M | -$9.1M | -$11.4M | |
Basic EPS (Cont. Ops) | -$3.13 | -$2.07 | -$0.87 | -$0.49 | -$0.61 | |
Diluted EPS (Cont. Ops) | -$3.13 | -$2.07 | -$0.87 | -$0.49 | -$0.61 | |
Weighted Average Basic Share | $17.4M | $18.1M | $18.8M | $18.8M | $18.6M | |
Weighted Average Diluted Share | $17.4M | $18.1M | $18.8M | $18.8M | $18.6M | |
EBITDA | -$47.3M | -$46.5M | -$53.4M | -$51.6M | -$48.5M | |
EBIT | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M | |
Revenue (Reported) | $921K | $1.1M | $1.9M | $4.2M | $6M | |
Operating Income (Reported) | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M | |
Operating Income (Adjusted) | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $181K | $335K | $608K | $1.3M | $1.4M | |
Revenue Growth (YoY) | -44.65% | 85.08% | 81.49% | 107.24% | 10.24% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | $181K | $335K | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $1.3M | $767K | $1.4M | $2.2M | $1.1M | |
Selling, General & Admin | $9.8M | $10.9M | $12.3M | $11.3M | $10.8M | |
Other Inc / (Exp) | -$55K | $1M | $29.1M | $2M | $20M | |
Operating Expenses | $11.3M | $12.1M | $14M | $13.8M | $12M | |
Operating Income | -$11.1M | -$11.8M | -$13.4M | -$12.5M | -$10.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$11.1M | -$10.7M | $16.2M | -$9.5M | $9.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$187K | $273K | $637K | -$130K | $674K | |
Net Income to Company | -$10.9M | -$11M | $15.5M | -$9.4M | $9.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$10.9M | -$11M | $15.5M | -$9.4M | $9.2M | |
Basic EPS (Cont. Ops) | -$0.62 | -$0.60 | $0.82 | -$0.51 | $0.50 | |
Diluted EPS (Cont. Ops) | -$0.62 | -$0.60 | $0.82 | -$0.51 | $0.49 | |
Weighted Average Basic Share | $17.6M | $18.4M | $18.9M | $18.5M | $18.6M | |
Weighted Average Diluted Share | $17.6M | $18.4M | $18.9M | $18.5M | $18.6M | |
EBITDA | -$11M | -$11.3M | -$13.1M | -$12.3M | -$10.5M | |
EBIT | -$11.1M | -$11.8M | -$13.4M | -$12.5M | -$10.6M | |
Revenue (Reported) | $181K | $335K | $608K | $1.3M | $1.4M | |
Operating Income (Reported) | -$11.1M | -$11.8M | -$13.4M | -$12.5M | -$10.6M | |
Operating Income (Adjusted) | -$11.1M | -$11.8M | -$13.4M | -$12.5M | -$10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $921K | $1.1M | $1.9M | $4.2M | $6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -$685K | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.3M | $3.6M | $4.4M | $5.7M | $5.7M | |
Selling, General & Admin | $42.2M | $44M | $50.9M | $50.1M | $48.8M | |
Other Inc / (Exp) | -$3.7M | $11.4M | $38.7M | $42.6M | $37.4M | |
Operating Expenses | $50.1M | $49M | $56.8M | $56.7M | $55.1M | |
Operating Income | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$54.3M | -$36.5M | -$15.1M | -$7.5M | -$9.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $124K | $983K | $1.3M | $1.6M | $1.9M | |
Net Income to Company | -$54.4M | -$37.5M | -$16.3M | -$9.1M | -$11.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$54.4M | -$37.5M | -$16.3M | -$9.1M | -$11.4M | |
Basic EPS (Cont. Ops) | -$3.13 | -$2.07 | -$0.87 | -$0.49 | -$0.62 | |
Diluted EPS (Cont. Ops) | -$3.13 | -$2.07 | -$0.87 | -$0.49 | -$0.63 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$47.3M | -$46.5M | -$53.4M | -$51.6M | -$48.5M | |
EBIT | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M | |
Revenue (Reported) | $921K | $1.1M | $1.9M | $4.2M | $6M | |
Operating Income (Reported) | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M | |
Operating Income (Adjusted) | -$50.8M | -$48M | -$54.9M | -$52.5M | -$49M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.1M | $1.9M | $4.2M | $6M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $5K | -- | -- | -- | -- | |
Gross Profit | $715K | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.6M | $4.4M | $5.7M | $5.7M | -- | |
Selling, General & Admin | $44M | $50.9M | $50.1M | $48.8M | -- | |
Other Inc / (Exp) | $11.4M | $38.7M | $42.6M | $37.4M | -- | |
Operating Expenses | $49M | $56.8M | $56.7M | $55.1M | -- | |
Operating Income | -$48M | -$54.9M | -$52.5M | -$49M | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$36.5M | -$15.1M | -$7.5M | -$9.5M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $983K | $1.3M | $1.6M | $1.9M | -- | |
Net Income to Company | -$37.5M | -$16.3M | -$9.1M | -$11.4M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$37.5M | -$16.3M | -$9.1M | -$11.4M | -- | |
Basic EPS (Cont. Ops) | -$2.07 | -$0.87 | -$0.49 | -$0.62 | -- | |
Diluted EPS (Cont. Ops) | -$2.07 | -$0.87 | -$0.49 | -$0.63 | -- | |
Weighted Average Basic Share | $72.3M | $75.4M | $75.1M | $74.3M | -- | |
Weighted Average Diluted Share | $72.3M | $75.4M | $75.5M | $74.4M | -- | |
EBITDA | -$46.5M | -$53.4M | -$51.6M | -$48.5M | -- | |
EBIT | -$48M | -$54.9M | -$52.5M | -$49M | -- | |
Revenue (Reported) | $1.1M | $1.9M | $4.2M | $6M | -- | |
Operating Income (Reported) | -$48M | -$54.9M | -$52.5M | -$49M | -- | |
Operating Income (Adjusted) | -$48M | -$54.9M | -$52.5M | -$49M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $117.5M | $105.6M | $43.2M | $60.6M | $47.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $4K | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $3.5M | -- | -- | -- | -- | |
Other Current Assets | -- | $10.1M | $2.4M | $3.9M | $2.8M | |
Total Current Assets | $121.1M | $115.8M | $59.5M | $73M | $60.8M | |
Property Plant And Equipment | $8.7M | $7M | $7M | $6.5M | $6.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $122.1M | $151.2M | $202M | $216.7M | $229M | |
Other Long-Term Assets | $1.2M | $4.1M | $1.2M | $8.9M | $8.3M | |
Total Assets | $253.1M | $278M | $278.6M | $324.9M | $333.1M | |
Accounts Payable | $500K | $1M | $755K | $696K | $1.1M | |
Accrued Expenses | $5.8M | $5.5M | $5.9M | $7M | $7.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.5M | $1.5M | $1.7M | $1.9M | $1.6M | |
Other Current Liabilities | -- | -- | $20.2M | $1M | $8.1M | |
Total Current Liabilities | $8.6M | $9.6M | $31.9M | $18M | $27.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $40.5M | $91.7M | $98.8M | $163.9M | $176.5M | |
Common Stock | $2K | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $212.5M | $186.3M | $179.8M | $161M | $156.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $212.5M | $186.3M | $179.8M | $161M | $156.6M | |
Total Liabilities and Equity | $253.1M | $278M | $278.6M | $324.9M | $333.1M | |
Cash and Short Terms | $117.5M | $105.6M | $43.2M | $60.6M | $47.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $117.5M | $105.6M | $43.2M | $60.6M | $47.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $4K | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $3.5M | -- | -- | -- | -- | |
Other Current Assets | -- | $10.1M | $2.4M | $3.9M | $2.8M | |
Total Current Assets | $121.1M | $115.8M | $59.5M | $73M | $60.8M | |
Property Plant And Equipment | $8.7M | $7M | $7M | $6.5M | $6.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $122.1M | $151.2M | $202M | $216.7M | $229M | |
Other Long-Term Assets | $1.2M | $4.1M | $1.2M | $8.9M | $8.3M | |
Total Assets | $253.1M | $278M | $278.6M | $324.9M | $333.1M | |
Accounts Payable | $500K | $1M | $755K | $696K | $1.1M | |
Accrued Expenses | $5.8M | $5.5M | $5.9M | $7M | $7.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.5M | $1.5M | $1.7M | $1.9M | $1.6M | |
Other Current Liabilities | -- | -- | $20.2M | $1M | $8.1M | |
Total Current Liabilities | $8.6M | $9.6M | $31.9M | $18M | $27.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $40.5M | $91.7M | $98.8M | $163.9M | $176.5M | |
Common Stock | $2K | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $212.5M | $186.3M | $179.8M | $161M | $156.6M | |
Total Liabilities and Equity | $253.1M | $278M | $278.6M | $324.9M | $333.1M | |
Cash and Short Terms | $117.5M | $105.6M | $43.2M | $60.6M | $47.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$54.4M | -$37.5M | -$16.3M | -$9.1M | -$11.4M | |
Depreciation & Amoritzation | $3.5M | $1.5M | $1.4M | $844K | $548K | |
Stock-Based Compensation | $15.9M | $13.6M | $17.9M | $15.5M | $13.5M | |
Change in Accounts Receivable | $57K | $4K | -- | -- | -$2.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$10M | $17.9M | -$27.3M | $42M | -$29.3M | |
Capital Expenditures | $14.2M | $27.4M | $27.1M | $17.3M | $18.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$14.2M | -$27.4M | -$27.1M | $8.1M | $22.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$15M | -$8.2M | -$24.7M | -$8.4M | |
Other Financing Activities | -- | -$1.5M | -$1.6M | -$1.2M | -$1.8M | |
Cash From Financing | $4.2M | -$2.4M | -$8.1M | -$25.1M | -$6.6M | |
Beginning Cash (CF) | $137.5M | $117.5M | $105.6M | $43.2M | $68.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$19.9M | -$11.9M | -$62.4M | $24.9M | -$13.1M | |
Ending Cash (CF) | $117.5M | $105.6M | $43.2M | $68.1M | $55M | |
Levered Free Cash Flow | -$24.1M | -$9.5M | -$54.4M | $24.7M | -$47.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$10.9M | -$11M | $15.5M | -$9.4M | $9.2M | |
Depreciation & Amoritzation | $115K | $454K | $313K | $191K | $76K | |
Stock-Based Compensation | $2.7M | $3.6M | $4.5M | $3.5M | $2.9M | |
Change in Accounts Receivable | $15K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $10.7M | -$9.1M | -$8.6M | $6.1M | -$16.6M | |
Capital Expenditures | $3.1M | $11.1M | $6.5M | $2.3M | $5.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$3.1M | -$11.1M | -$6.5M | -$2.3M | $35.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$3M | -- | -$6M | -$2M | |
Other Financing Activities | -- | -- | -$91K | -$104K | -- | |
Cash From Financing | $1.4M | -$1.9M | $763K | -$5.3M | -$264K | |
Beginning Cash (CF) | $108.5M | $127.8M | $57.5M | $69.6M | $36.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9.1M | -$22.1M | -$14.3M | -$1.4M | $18.6M | |
Ending Cash (CF) | $117.5M | $105.6M | $43.2M | $68.1M | $55M | |
Levered Free Cash Flow | $7.7M | -$20.3M | -$15.1M | $3.9M | -$22.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$54.4M | -$37.5M | -$16.3M | -$9.1M | -$11.4M | |
Depreciation & Amoritzation | $3.5M | $1.5M | $1.4M | $844K | $548K | |
Stock-Based Compensation | $15.9M | $13.6M | $17.9M | $15.5M | $13.5M | |
Change in Accounts Receivable | $57K | $4K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$10M | $17.9M | -$27.3M | $42M | -$29.3M | |
Capital Expenditures | $14.2M | $27.4M | $27.1M | $17.3M | $18.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$14.2M | -$27.4M | -$27.1M | $8.1M | $22.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$15M | -$8.2M | -$24.7M | -$8.4M | |
Other Financing Activities | -- | -- | -$1.6M | -$1.2M | -$1.8M | |
Cash From Financing | $4.2M | -$2.4M | -$8.1M | -$25.1M | -$6.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$19.9M | -$11.9M | -$62.4M | $24.9M | -$13.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$24.1M | -$9.5M | -$54.4M | $24.7M | -$47.4M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$37.5M | -$16.3M | -$9.1M | -$11.4M | -- | |
Depreciation & Amoritzation | $1.5M | $1.4M | $844K | $548K | -- | |
Stock-Based Compensation | $13.6M | $17.9M | $15.5M | $13.5M | -- | |
Change in Accounts Receivable | $4K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $17.9M | -$27.3M | $42M | -$29.3M | -- | |
Capital Expenditures | $27.4M | $27.1M | $17.3M | $18.2M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$27.4M | -$27.1M | $8.1M | $22.8M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$15M | -$8.2M | -$24.7M | -$8.4M | -- | |
Other Financing Activities | -$1.5M | -$1.6M | -$1.2M | -$1.8M | -- | |
Cash From Financing | -$2.4M | -$8.1M | -$25.1M | -$6.6M | -- | |
Beginning Cash (CF) | $453.1M | $319.7M | $190.3M | $214.6M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$11.9M | -$62.4M | $24.9M | -$13.1M | -- | |
Ending Cash (CF) | $441.2M | $257.3M | $215.2M | $201.5M | -- | |
Levered Free Cash Flow | -$9.5M | -$54.4M | $24.7M | -$47.4M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.